210 related articles for article (PubMed ID: 10584701)
1. Retroperitoneal liposarcoma with combined well-differentiated and myxoid malignant fibrous histiocytoma-like myxoid areas.
Hisaoka M; Morimitsu Y; Hashimoto H; Ishida T; Mukai H; Satoh H; Motoi T; Machinami R
Am J Surg Pathol; 1999 Dec; 23(12):1480-92. PubMed ID: 10584701
[TBL] [Abstract][Full Text] [Related]
2. Dedifferentiated myxoid liposarcoma: a clinicopathological study suggesting a closer relationship between myxoid and well-differentiated liposarcoma.
Mentzel T; Fletcher CD
Histopathology; 1997 May; 30(5):457-63. PubMed ID: 9181367
[TBL] [Abstract][Full Text] [Related]
3. Detection of TLS/FUS-CHOP fusion transcripts in myxoid and round cell liposarcomas by nested reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues.
Hisaoka M; Tsuji S; Morimitsu Y; Hashimoto H; Shimajiri S; Komiya S; Ushijima M
Diagn Mol Pathol; 1998 Apr; 7(2):96-101. PubMed ID: 9785008
[TBL] [Abstract][Full Text] [Related]
4. Chimeric TLS/FUS-CHOP gene expression and the heterogeneity of its junction in human myxoid and round cell liposarcoma.
Kuroda M; Ishida T; Horiuchi H; Kida N; Uozaki H; Takeuchi H; Tsuji K; Imamura T; Mori S; Machinami R
Am J Pathol; 1995 Nov; 147(5):1221-7. PubMed ID: 7485386
[TBL] [Abstract][Full Text] [Related]
5. Limited role of TP53 and TP53-related genes in myxoid liposarcoma.
Pilotti S; Lavarino C; Mezzelani A; Della Torre C; Minoletti F; Sozzi G; Azzarelli A; Rilke F; Pierotti MA
Tumori; 1998; 84(5):571-7. PubMed ID: 9862519
[TBL] [Abstract][Full Text] [Related]
6. Distinct mdm2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms.
Pilotti S; Della Torre G; Lavarino C; Di Palma S; Sozzi G; Minoletti F; Rao S; Pasquini G; Azzarelli A; Rilke F; Pierotti MA
J Pathol; 1997 Jan; 181(1):14-24. PubMed ID: 9071998
[TBL] [Abstract][Full Text] [Related]
7. FUS/TLS-CHOP chimeric transcripts in liposarcoma tissues.
Yang X; Nagasaki K; Egawa S; Maruyama K; Futami H; Tsukada T; Yokoyama R; Beppu Y; Fukuma H; Shimoda T
Jpn J Clin Oncol; 1995 Dec; 25(6):234-9. PubMed ID: 8523819
[TBL] [Abstract][Full Text] [Related]
8. No correlation of c-myc overexpression and p53 mutations in liposarcomas.
Schneider-Stock R; Walter H; Rys J; Radig K; Hoang-Vu C; Roessner A
Virchows Arch; 1998 Oct; 433(4):315-21. PubMed ID: 9808433
[TBL] [Abstract][Full Text] [Related]
9. Interphase cytogenetic analysis of myxoid soft tissue tumors by fluorescence in situ hybridization and DNA flow cytometry using paraffin-embedded tissue.
Aoki T; Hisaoka M; Kouho H; Hashimoto H; Nakata H
Cancer; 1997 Jan; 79(2):284-93. PubMed ID: 9010102
[TBL] [Abstract][Full Text] [Related]
10. [Well-differentiated/dedifferentiated liposarcoma associated with myxoid-like morphology: a clinicopathological and molecular genetic characteristics analysis of 34 cases].
Xue S; Liu QY; Gou XN; Zhao YW; Cheng Q; Kong LF
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):168-173. PubMed ID: 38281785
[No Abstract] [Full Text] [Related]
11. Molecular aberrations of the G1-S checkpoint in myxoid and round cell liposarcoma.
Dei Tos AP; Piccinin S; Doglioni C; Vukosavljevic T; Mentzel T; Boiocchi M; Fletcher CD
Am J Pathol; 1997 Dec; 151(6):1531-9. PubMed ID: 9403703
[TBL] [Abstract][Full Text] [Related]
12. A clinicopathologic comparison of malignant fibrous histiocytoma and liposarcoma.
Spanier SS; Floyd J
Instr Course Lect; 1989; 38():407-17. PubMed ID: 2539413
[TBL] [Abstract][Full Text] [Related]
13. Molecular abnormalities of the p53 pathway in dedifferentiated liposarcoma.
Dei Tos AP; Doglioni C; Piccinin S; Maestro R; Mentzel T; Barbareschi M; Boiocchi M; Fletcher CD
J Pathol; 1997 Jan; 181(1):8-13. PubMed ID: 9071997
[TBL] [Abstract][Full Text] [Related]
14. Dedifferentiated liposarcoma. Clinicopathologic analysis of 32 cases suggesting a better prognostic subgroup among pleomorphic sarcomas.
McCormick D; Mentzel T; Beham A; Fletcher CD
Am J Surg Pathol; 1994 Dec; 18(12):1213-23. PubMed ID: 7977944
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical status of p53, mdm2 and Ki-67 in malignant fibrous histiocytoma.
Szadowska A; Olborski B; Harezga-Bal B; Debiec-Rychter M
Pol J Pathol; 1998; 49(1):15-21. PubMed ID: 9640970
[TBL] [Abstract][Full Text] [Related]
16. Atypical and malignant neoplasms showing lipomatous differentiation. A study of 111 cases.
Azumi N; Curtis J; Kempson RL; Hendrickson MR
Am J Surg Pathol; 1987 Mar; 11(3):161-83. PubMed ID: 3826477
[TBL] [Abstract][Full Text] [Related]
17. Molecular abnormalities in liposarcoma: role of MDM2 and CDK4-containing amplicons at 12q13-22.
Pilotti S; Della Torre G; Lavarino C; Sozzi G; Minoletti F; Vergani B; Azzarelli A; Rilke F; Pierotti MA
J Pathol; 1998 Jun; 185(2):188-90. PubMed ID: 9713346
[TBL] [Abstract][Full Text] [Related]
18. Molecular and immunohistochemical p53 status in liposarcoma and malignant fibrous histiocytoma: identification of seven new mutations for soft tissue sarcomas.
Taubert H; Würl P; Meye A; Berger D; Thamm B; Neumann K; Hinze R; Schmidt H; Rath FW
Cancer; 1995 Oct; 76(7):1187-96. PubMed ID: 8630896
[TBL] [Abstract][Full Text] [Related]
19. S-100 protein distribution in liposarcoma. An immunoperoxidase study with special reference to the distinction of liposarcoma from myxoid malignant fibrous histiocytoma.
Hashimoto H; Daimaru Y; Enjoji M
Virchows Arch A Pathol Anat Histopathol; 1984; 405(1):1-10. PubMed ID: 6095521
[TBL] [Abstract][Full Text] [Related]
20. Specificity of TLS-CHOP rearrangement for classic myxoid/round cell liposarcoma: absence in predominantly myxoid well-differentiated liposarcomas.
Antonescu CR; Elahi A; Humphrey M; Lui MY; Healey JH; Brennan MF; Woodruff JM; Jhanwar SC; Ladanyi M
J Mol Diagn; 2000 Aug; 2(3):132-8. PubMed ID: 11229517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
